Phagotherapy: a support for the work on bacteriophages of a Franco-American team (Institut Pasteur and Georgia Tech)

An interdisciplinary team of researchers at the Institut Pasteur and the Georgia Institute of Technology has received a $2.5 million National Institutes of Health (NIH) grant to study phage therapy. This project aims to deepen the fundamental knowledge and the clinical potential of bacteria-killing viruses – also called bacteriophage, or phage –, to treat antibiotic-resistant infection.

Over the five years of the award, Laurent Debarbieux of the Institut Pasteur, in Paris, and Joshua Weitz of the School of Biological Sciences at Georgia Tech will jointly lead teams in the U.S. and France to research interactions between bacteriophage and the host’s immune response in treating acute respiratory infections caused by multi-drug-resistant bacteria.

Find out more